Rethinking Diabetes Meds in the OR
About this episode
This episode discusses the implications of diabetes medications in the operating room and the latest evidence regarding their management.
Every fifth patient you anesthetize has diabetes, and the medications they're on are no longer just a pre-op checkbox. In this podcast, we dissect the latest evidence: why GLP-1 agonists may be safer to continue than to stop, what the SGLT-2 data is really telling us, and the shift toward highly personalized, evidence-based risk assessments.. Read more about this topic HERE . ====================================== Where else to find us: Web - https://www.nysora.com/ Instagram - instagram.com/nysora.inc/ LinkedIn - linkedin.com/company/nysora-inc/ Facebook - facebook.com/nysora Twitter - x.com/nysora TikTok - tiktok.com/@nysora_inc --------------------------------------------------------- #nysora #regionalanesthesia #anesthesia Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate…
People in this episode
Host: NYSORA
Topics covered
- diabetes
- anesthesia
- medication management
- personalized medicine
- risk assessment
Keywords
- diabetes
- anesthesia
- GLP-1 agonists
- SGLT-2
- medication safety
- personalized risk assessment
Mentioned in this episode
Products: GLP-1 agonists, SGLT-2
Places: OR
More episodes of Anesthesia Updates
- SGLT2 Inhibitors Before Surgery: Time to Rethink?
- Frailty or Age?
- AI and Anesthesia Education
- Pediatric Regional Anesthesia: What the Evidence Actually Says
Explore listener stats, chart rankings, contacts and more on the Anesthesia Updates podcast page.